Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-14

FDA Approved: HYDROMORPHONE HYDROCHLORIDE — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved hydromorphone hydrochloride from Hikma Pharmaceuticals USA Inc. under Original Application NDA217812 for pain management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydromorphone hydrochloride (hydromorphone hydrochloride)

Snippet

ORIG AP for HYDROMORPHONE HYDROCHLORIDE (HYDROMORPHONE HYDROCHLORIDE)